Expansion in pain management remains a major opportunity.Postoperative and neuropathic pain treatments drive usage.Patients unable to swallow tablets benefit significantly. The Oral Transmucosal Drugs Market is poised for steady expansion, registering a projected CAGR of 6.6% from 2025 to 2031. The market is expected to grow from US$ XX million in 2024 to US$ XX million by 2031, reflecting...

Fentanyl-based transmucosal products are widely adopted.They are commonly used for managing breakthrough cancer pain.Rapid relief makes them highly valuable in clinical practice. \The Oral Transmucosal Drugs Market is poised for steady expansion, registering a projected CAGR of 6.6% from 2025 to 2031. The market is expected to grow from US$ XX million in 2024 to US$ XX million by 2031,...